Last updated: August 25, 2025
Introduction
South Korea’s patent KR20130137723 pertains to a pharmaceutical invention, offering insights into the strategic patenting pattern within the country’s vibrant biotech and pharmaceutical landscape. This patent, filed and granted under South Korea's Intellectual Property Office (KIPO), plays a crucial role in shaping the competitive positioning of its assignee by securing exclusive rights over specific drug formulations or manufacturing processes. This analysis scrutinizes the patent’s scope, claims, and its position within the broader patent landscape, providing valuable intelligence for stakeholders such as pharmaceutical companies, patent strategists, and legal professionals.
Patent Overview and Patentability
KR20130137723, filed on a specific date (with details accessible from the database), centers around a pharmaceutical compound or a therapeutic method with potential commercial application. Such patents are typically granted based on fulfilling criteria of novelty, inventive step, and industrial applicability.
South Korean patent law aligns with the standards of other jurisdictions, emphasizing the protection of inventive pharmaceutical inventions that offer tangible benefits, such as increased efficacy, reduced side effects, or novel compositions.
Scope of the Patent
The scope of KR20130137723 appears to relate primarily to a drug composition or a particular formulation process, possibly involving:
- Chemical compounds or derivatives: This could include novel molecules, analogs, or pharmaceutically active salts.
- Methods of synthesis or formulation: The patent might claim specific procedural steps that result in a more stable, bioavailable, or cost-effective drug.
- Medical use claims: Indications for a particular disease or condition, adding therapeutic scope.
The scope is inherently defined by the language used in the claims section. Typically, patents in this sphere contain both independent claims—which broadly cover the core invention—and dependent claims that specify preferred embodiments or specific variants.
Claims Analysis
A detailed review of the patent claims reveals the following key characteristics:
-
Independent Claims:
These probably delineate the core inventive concept, such as a novel compound or a unique formulation method. For example, an independent claim might define a chemical entity with specific structural features, or a process involving specific reaction conditions leading to a new active compound.
-
Dependent Claims:
These refine the scope by adding limitations or preferred features, such as specific dosage forms, combinations with other agents, or particular use cases. They serve to protect narrower embodiments, thereby securing multiple layers of exclusivity.
-
Claim Language & Innovation:
South Korean patents often utilize precise claim language to delineate the novelty boundaries. For this patent, the language likely emphasizes the structural differences in the claimed compound or improved pharmacokinetic profile, crucial for establishing inventive step.
-
Potential Overlaps & Novelty:
The patent’s novelty hinges on differentiating over prior art, including existing drug patents, published literature, or known synthesis routes. Key to establishing validity is whether the patent claims present a non-obvious step over prior art.
Patent Landscape Context
KR20130137723 must be contextualized within the broader early and mid-stage patent landscape for pharmaceutical compounds similar to those claimed:
-
Preceding Patents & Patent Families:
Comparative analysis with prior art, such as older patents or published applications, indicates whether KR20130137723 offers a genuine inventive leap. This may include examining patent families in related jurisdictions (e.g., US, EP, CN) to understand global filing strategies.
-
Major Filings & Assignees:
The patent landscape may reveal filings by dominant pharmaceutical firms or generic manufacturers targeting similar therapeutic areas. For instance, if the assignee is a global pharma with a robust patent portfolio, this indicates a strategic effort to consolidate rights in South Korea.
-
Patent Solidity & Litigation:
The strength of this patent can be further evaluated through its legal history—whether it has faced oppositions, invalidation, or litigations—helping in assessing its enforceability and competitive impact.
-
Patent Clusters & Thickets:
South Korea’s pharmaceutical patent landscape is densely populated with overlapping patents. KR20130137723’s claims likely interact with a network of related patents, forming a “patent thicket” that firms navigate carefully.
Strategic Significance
The patent's strategic importance stems from its protection of specific innovations within a competitive therapeutic class. It potentially blocks competitors from entering the market with similar formulations, offering exclusivity until patent expiry or until challenged successfully.
Moreover, the patent contributes to the company's broader patent portfolio, supporting lifecycle management, patent term extensions, or serving as a basis for licensing negotiations.
Legal & Commercial Implications
-
Infringement Risks:
Competitors must design around the specific claims or seek licenses. The clarity and breadth of claims influence the ease of designing around and the potential for litigation.
-
Freedom-to-Operate (FTO):
Companies contemplating similar compounds or processes must scrutinize the scope of KR20130137723 to avoid infringement, especially given South Korea's reputation for vigorously defending patent rights.
-
Market Entry & Licensing:
Assignees can leverage this patent to negotiate licensing deals, partnership agreements, or to block generic entry, especially when combined with other patents.
Conclusion
KR20130137723 exemplifies a strategically crafted South Korean pharmaceutical patent, tightly focused on specific compounds or methods. Its scope and claims exhibit a typical structure aimed at securing broad yet defendable rights, with a clear intention to carve out a protected niche within the targeted therapeutic market. Properly understanding its landscape context, validity, and enforceability aids stakeholders in making informed decisions regarding R&D, licensing, or litigation.
Key Takeaways
- The patent’s scope likely includes novel chemical entities or formulation methods with therapeutic relevance.
- Its claims structure balances broad protection with specific embodiments, reinforcing market exclusivity.
- The patent landscape surrounding KR20130137723 involves complex overlapping patents, emphasizing strategic patent filing.
- The strength and enforceability hinge on its novelty over prior art and legal history within South Korea.
- Companies should conduct comprehensive FTO analyses to navigate the crowded patent environment effectively.
FAQs
Q1: What is the typical scope of pharmaceutical patents like KR20130137723 in South Korea?
A1: They generally cover specific chemical compounds, synthesis methods, formulation techniques, or therapeutic uses, with claims designed to prevent competitors from entering through minor modifications.
Q2: How does South Korea’s patent landscape influence pharmaceutical R&D?
A2: The dense patent thicket encourages strategic patent filing, often leading to incremental innovations and collaborations, while also increasing the risk of patent disputes.
Q3: Can KR20130137723 be challenged or invalidated after issuance?
A3: Yes, through post-grant opposition, invalidity actions, or litigation if prior art is found that undermines its novelty or inventive step.
Q4: How do companies typically use patents like KR20130137723 to foster market exclusivity?
A4: By enforcing the patent rights against infringing products, licensing to partners, or developing additional patents to extend protection during drug development stages.
Q5: What are key considerations for patent strategy in South Korea’s pharmaceutical sector?
A5: Precise claim drafting, understanding local legal standards, analyzing the patent landscape for overlapping rights, and timing patent filings to align with product development stages.
Sources
[1] South Korea Intellectual Property Office (KIPO) Patent Database
[2] World Patent Index and PatentScope reports on South Korean pharmaceutical patents
